170 related articles for article (PubMed ID: 25374060)
21. MicroRNA-1469-5p promotes the invasion and proliferation of pancreatic cancer cells via direct regulating the NDRG1/NF-κB/E-cadherin axis.
Liu J; Zhu C; Zhang L; Lu H; Wang Z; Lv J; Fan C
Hum Cell; 2020 Oct; 33(4):1176-1185. PubMed ID: 32757096
[TBL] [Abstract][Full Text] [Related]
22. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-κB signaling pathway.
Wang L; Zhou W; Zhong Y; Huo Y; Fan P; Zhan S; Xiao J; Jin X; Gou S; Yin T; Wu H; Liu T
Mol Cancer; 2017 Mar; 16(1):61. PubMed ID: 28288630
[TBL] [Abstract][Full Text] [Related]
24. Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-κB/STAT3 and NF-κB/CSN5 signaling pathways.
Ruan Z; Liang M; Shang L; Lai M; Deng X; Su X
Pancreatology; 2021 Apr; 21(3):630-641. PubMed ID: 33707115
[TBL] [Abstract][Full Text] [Related]
25. Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids.
Sharbeen G; McCarroll J; Liu J; Youkhana J; Limbri LF; Biankin AV; Johns A; Kavallaris M; Goldstein D; Phillips PA
Neoplasia; 2016 Dec; 18(12):753-764. PubMed ID: 27889644
[TBL] [Abstract][Full Text] [Related]
26. Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathway.
Zheng C; Jia W; Tang Y; Zhao H; Jiang Y; Sun S
J Exp Clin Cancer Res; 2012 Oct; 31(1):84. PubMed ID: 23034174
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
Han Q; Li J; Xiong J; Song Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
[TBL] [Abstract][Full Text] [Related]
28. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
[TBL] [Abstract][Full Text] [Related]
29. Cloning, gene regulation, and neuronal proliferation functions of novel N-terminal-truncated carboxypeptidase E/neurotrophic factor-αl variants in embryonic mouse brain.
Xiao L; Yang X; Sharma VK; Loh YP
FASEB J; 2019 Jan; 33(1):808-820. PubMed ID: 30063439
[TBL] [Abstract][Full Text] [Related]
30. The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.
He S; Niu G; Shang J; Deng Y; Wan Z; Zhang C; You Z; Shen H
J Exp Clin Cancer Res; 2017 Oct; 36(1):137. PubMed ID: 28978336
[TBL] [Abstract][Full Text] [Related]
31. The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress.
Höring E; Harter PN; Seznec J; Schittenhelm J; Bühring HJ; Bhattacharyya S; von Hattingen E; Zachskorn C; Mittelbronn M; Naumann U
Acta Neuropathol; 2012 Jul; 124(1):83-97. PubMed ID: 22249620
[TBL] [Abstract][Full Text] [Related]
32. MiR‑203 regulates the proliferation, apoptosis and cell cycle progression of pancreatic cancer cells by targeting Survivin.
Xu D; Wang Q; An Y; Xu L
Mol Med Rep; 2013 Aug; 8(2):379-84. PubMed ID: 23732815
[TBL] [Abstract][Full Text] [Related]
33. The influence of SnoN gene silencing by siRNA on the cell proliferation and apoptosis of human pancreatic cancer cells.
Liu C; Zhang H; Zang X; Wang C; Kong Y; Zhang H
Diagn Pathol; 2015 Apr; 10():30. PubMed ID: 25907906
[TBL] [Abstract][Full Text] [Related]
34. Interaction between microRNA-181a and TNFAIP1 regulates pancreatic cancer proliferation and migration.
Zhang P; Guo Z; Hu R; He X; Jiao X; Zhu X
Tumour Biol; 2015 Dec; 36(12):9693-701. PubMed ID: 26152285
[TBL] [Abstract][Full Text] [Related]
35. Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis.
Lin SZ; Wei WT; Chen H; Chen KJ; Tong HF; Wang ZH; Ni ZL; Liu HB; Guo HC; Liu DL
PLoS One; 2012; 7(8):e42146. PubMed ID: 22876305
[TBL] [Abstract][Full Text] [Related]
36. Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy.
Radhakrishnan P; Bryant VC; Blowers EC; Rajule RN; Gautam N; Anwar MM; Mohr AM; Grandgenett PM; Bunt SK; Arnst JL; Lele SM; Alnouti Y; Hollingsworth MA; Natarajan A
Clin Cancer Res; 2013 Apr; 19(8):2025-35. PubMed ID: 23444213
[TBL] [Abstract][Full Text] [Related]
37. Exosomal Carboxypeptidase E (CPE) and CPE-shRNA-Loaded Exosomes Regulate Metastatic Phenotype of Tumor Cells.
Hareendran S; Albraidy B; Yang X; Liu A; Breggia A; Chen CC; Loh YP
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328535
[TBL] [Abstract][Full Text] [Related]
38. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146
[TBL] [Abstract][Full Text] [Related]
39. Inhibiting the NF-κB pathway enhances the antitumor effect of cabazitaxel by downregulating Bcl-2 in pancreatic cancer.
Li Z; Xuan Z; Chen J; Song W; Zhang S; Jin C; Zhou M; Zheng S; Song P
Int J Oncol; 2020 Jul; 57(1):161-170. PubMed ID: 32377719
[TBL] [Abstract][Full Text] [Related]
40. UCA1 Regulates the Growth and Metastasis of Pancreatic Cancer by Sponging miR-135a.
Zhang X; Gao F; Zhou L; Wang H; Shi G; Tan X
Oncol Res; 2017 Nov; 25(9):1529-1541. PubMed ID: 28315290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
